JP2004512824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004512824A5 JP2004512824A5 JP2002509377A JP2002509377A JP2004512824A5 JP 2004512824 A5 JP2004512824 A5 JP 2004512824A5 JP 2002509377 A JP2002509377 A JP 2002509377A JP 2002509377 A JP2002509377 A JP 2002509377A JP 2004512824 A5 JP2004512824 A5 JP 2004512824A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- sequence
- seq
- antigen
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 description 15
- 239000002157 polynucleotide Substances 0.000 description 8
- 229920000023 polynucleotide Polymers 0.000 description 7
- 102000004965 antibodies Human genes 0.000 description 6
- 108090001123 antibodies Proteins 0.000 description 6
- 210000001744 T-Lymphocytes Anatomy 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000038129 antigens Human genes 0.000 description 5
- 108091007172 antigens Proteins 0.000 description 5
- 210000004027 cells Anatomy 0.000 description 4
- 102000037240 fusion proteins Human genes 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- 230000004936 stimulating Effects 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 210000000612 Antigen-Presenting Cells Anatomy 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 230000003344 immunostimulant Effects 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/614,124 US6630574B1 (en) | 1999-06-30 | 2000-07-11 | Compositions and methods for the therapy and diagnosis of lung cancer |
| US09/651,563 US6914132B1 (en) | 1999-06-30 | 2000-08-29 | Compositions and methods for the therapy and diagnosis of lung cancer |
| US09/658,824 US6746846B1 (en) | 1999-06-30 | 2000-09-08 | Methods for diagnosing lung cancer |
| US09/671,325 US6667154B1 (en) | 1999-06-30 | 2000-09-26 | Compositions and methods for the therapy and diagnosis of lung cancer |
| US67741900A | 2000-10-06 | 2000-10-06 | |
| US09/702,705 US6504010B1 (en) | 1999-06-30 | 2000-10-30 | Compositions and methods for the therapy and diagnosis of lung cancer |
| US09/736,457 US6509448B2 (en) | 1999-06-30 | 2000-12-13 | Compositions and methods for the therapy and diagnosis of lung cancer |
| US09/849,626 US20020197669A1 (en) | 2000-12-13 | 2001-05-03 | Compositions and methods for the therapy and diagnosis of lung cancer |
| PCT/US2001/022058 WO2002004514A2 (en) | 2000-07-11 | 2001-07-10 | Compositions and methods for the therapy and diagnosis of lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004512824A JP2004512824A (ja) | 2004-04-30 |
| JP2004512824A5 true JP2004512824A5 (xx) | 2008-10-16 |
Family
ID=27575493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002509377A Pending JP2004512824A (ja) | 2000-07-11 | 2001-07-10 | 肺癌の治療および診断のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1343886A2 (xx) |
| JP (1) | JP2004512824A (xx) |
| AR (1) | AR031250A1 (xx) |
| AU (1) | AU2002218770A1 (xx) |
| CA (1) | CA2415544A1 (xx) |
| WO (1) | WO2002004514A2 (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030170255A1 (en) * | 1999-06-30 | 2003-09-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
| CA2490909A1 (en) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20030166300A1 (en) * | 2000-08-30 | 2003-09-04 | Tang Y. Tom | Growth-related inflammatory and immune response protein |
| ZA200204907B (en) * | 2001-06-26 | 2003-03-03 | Univ Nat Taiwan | Collapsin Response Mediator Protein-1. |
| EP1543018A4 (en) * | 2002-08-14 | 2006-10-25 | Lg Life Sciences Ltd | GENEVA ASSOCIATED WITH LIVER CANCER |
| AU2003263045A1 (en) * | 2002-09-26 | 2004-04-19 | Genentech, Inc. | Novel compositions and methods for the treatment of psoriasis |
| TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| US7449291B1 (en) | 2003-01-13 | 2008-11-11 | University Of Washington | Methods for identifying subjects susceptible to Charcot-Marie-Tooth neuropathy type 1C |
| WO2004070058A1 (en) * | 2003-02-03 | 2004-08-19 | Bayer Healthcare Ag | Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd |
| EP1606303A4 (en) * | 2003-03-24 | 2007-11-21 | Corixa Corp | PROOF AND OBSERVATION OF LUNG CANCER |
| EP2311468B1 (en) | 2003-08-08 | 2014-01-15 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| WO2005029067A2 (en) | 2003-09-24 | 2005-03-31 | Oncotherapy Science, Inc. | Method of diagnosing breast cancer |
| JP4428995B2 (ja) | 2003-12-03 | 2010-03-10 | 関東化学株式会社 | 金属膜のエッチング液組成物 |
| WO2006131783A2 (en) * | 2004-01-27 | 2006-12-14 | Compugen Usa, Inc. | Polynucleotides, polypeptides, and diagnosing lung cancer |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| US8940488B2 (en) | 2004-03-31 | 2015-01-27 | Hiroyuki Aburatani | Cancer diagnosis and treatment of cancer using anti-robo 1 antibody |
| DE602005022693D1 (de) | 2004-03-31 | 2010-09-16 | Perseus Proteomics Inc | Krebsdiagnose und behandlung unter verwendung eines anti-robo1-antikörpers |
| US7943295B2 (en) * | 2005-07-29 | 2011-05-17 | Oncotherapy Science, Inc. | Screening and therapeutic method for NSCLC targeting CDCA1-KNTC2 complex |
| US20110038849A1 (en) * | 2006-12-21 | 2011-02-17 | Intradigm Corporation | Inhibitory polynucleotide compositions and methods for treating cancer |
| JP5117765B2 (ja) | 2007-05-28 | 2013-01-16 | 国立大学法人 東京大学 | 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤 |
| JP5493076B2 (ja) | 2007-08-20 | 2014-05-14 | オンコセラピー・サイエンス株式会社 | Ｃｄｃａ１ペプチド及びこれを含む薬剤 |
| TWI526219B (zh) | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| JP5709108B2 (ja) * | 2009-05-22 | 2015-04-30 | 国立大学法人 岡山大学 | ＸＡＧＥ−１ｂ特異的免疫反応を誘導するペプチドおよびその利用 |
| JP6255593B2 (ja) | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Ｔｈ１細胞のＣＤＣＡ１エピトープペプチドおよびこれを含有するワクチン |
| CN114102955B (zh) * | 2020-08-31 | 2024-05-07 | 天津科技大学 | 一种采用常温发泡技术制备发泡聚乳酸的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10139800A (ja) * | 1996-11-15 | 1998-05-26 | Santen Pharmaceut Co Ltd | シェーグレン症候群治療剤 |
| ID27813A (id) * | 1998-01-28 | 2001-04-26 | Corixa Corp | Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya |
| AU3899700A (en) * | 1999-03-17 | 2000-10-04 | Alphagene, Inc. | Secreted proteins and polynucleotides encoding them |
| JP2004500029A (ja) * | 1999-06-30 | 2004-01-08 | コリクサ コーポレイション | 肺癌の治療および診断のための組成物および方法 |
-
2001
- 2001-07-10 JP JP2002509377A patent/JP2004512824A/ja active Pending
- 2001-07-10 EP EP01984164A patent/EP1343886A2/en not_active Withdrawn
- 2001-07-10 WO PCT/US2001/022058 patent/WO2002004514A2/en active Application Filing
- 2001-07-10 AU AU2002218770A patent/AU2002218770A1/en not_active Abandoned
- 2001-07-10 CA CA002415544A patent/CA2415544A1/en not_active Abandoned
- 2001-07-10 AR ARP010103274A patent/AR031250A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004512824A5 (xx) | ||
| JP2005504513A5 (xx) | ||
| JP2006515749A5 (xx) | ||
| JP2004512022A5 (xx) | ||
| JP2002532093A5 (xx) | ||
| RU2002121771A (ru) | Композиции и способы для терапии и диагностики рака предстательной железы | |
| CN113912710B (zh) | 抗新型冠状病毒n蛋白的单克隆抗体及其应用 | |
| JP2002542157A5 (xx) | ||
| JP2002515763A (ja) | Ｅｈｒｌｉｃｈｉａ感染の診断および処置のための化合物および方法 | |
| US10408840B2 (en) | Method for predicting clinical effect of immunotherapy | |
| RU2006134631A (ru) | Иммуногенные композиции против chlamidia pneumoniae | |
| EP2186884A2 (en) | HCV-anti-core monoclonal antibody | |
| WO2003037267B1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| JP2008515388A5 (xx) | ||
| EP3239176B1 (en) | Anti-active gip antibody | |
| US5780298A (en) | DNA encoding the sn-RNP-A antigen and fragments thereof | |
| WO1999005175A3 (en) | Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) | |
| JP2005506512A (ja) | 潜伏性ヒト結核モデル、診断用抗原、および使用法 | |
| JP2005507648A5 (xx) | ||
| JP2008509659A5 (xx) | ||
| EP2006681A1 (en) | Rheumatoid arthritis test method and treating method | |
| RU2002128922A (ru) | Композиции и способы для лечения и диагностики рака легких | |
| JP2005522209A5 (xx) | ||
| JP2006051019A5 (xx) | ||
| EP1796723B1 (en) | Method of diagnosing cancer by detecting the expression of spag9 or the presence of anti-spag9 antibodies |